Alkermes (ALKS) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Alkermes (ALKS) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99.56% |
| Mar 31, 2026 | -107.57% |
| Dec 31, 2025 | 108.23% |
| Sep 30, 2025 | 96.24% |
| Jun 30, 2025 | 93.70% |
| Mar 31, 2025 | -23.85% |
| Dec 31, 2024 | -857.64% |
| Sep 30, 2024 | 17.56% |
| Jun 30, 2024 | -62.69% |
| Mar 31, 2024 | 449.16% |
| Dec 31, 2023 | -68.70% |
| Sep 30, 2023 | 210.20% |
| Jun 30, 2023 | 746.25% |
| Mar 31, 2023 | 65.66% |
| Dec 31, 2022 | 123.99% |
| Sep 30, 2022 | -201.61% |
| Jun 30, 2022 | -862.07% |
| Mar 31, 2022 | -45.98% |
| Dec 31, 2021 | -3,026.59% |
| Sep 30, 2021 | -109.43% |